AzTrials
AzTrials

HypertensionNCT06557005

Facilitated Transitions From Postpartum to Primary Care Coordination for People With Chronic Conditions

A study testing Facilitated Transition to Primary Care in people with Hypertension and Diabetes, run by Massachusetts General Hospital at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The lack of postpartum primary care coordination is a missed opportunity to increase primary care engagement and manage chronic conditions early in life, especially for the >30% of pregnant people who have or are at risk for these conditions. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Hypertension, Diabetes, Postpartum
What is being tested?
Facilitated Transition to Primary Care
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,320 participants
Where
1 siteUnited States
Study dates
23 May 2025to 23 May 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Receiving obstetric care at an MGH-affiliated obstetrics practice (except for the MGH HOPE Clinic, which has a unique care model that provides prenatal and postnatal care for individuals with substance use disorder, including the provision of primary care through 2+ years postpartum)
  • Pregnant with a live fetus or delivered a live-born neonate ≥24 weeks of gestation, based on the clinical estimate of gestational age
  • If postpartum, has a neonate that is currently living at the time of enrollment
  • Has one or more of the following conditions listed in the "Problem List," "Medical History," or clinical notes during prenatal, intrapartum, or postpartum encounters in the EHR (or in the case of BMI, the patient's anthropometric measurements):
  • Chronic or essential hypertension
  • Hypertensive disorders related to pregnancy (e.g., pre-eclampsia)
Show all 14Show fewer
  • Type 1 or 2 diabetes (i.e., pre-existing diabetes)
  • Gestational diabetes
  • Class II Obesity (pre-pregnancy body mass index ≥35 kg/m2; or if pre-pregnancy body mass index is not known, a first trimester BMI of ≥35 kg/m2)
  • Depression or anxiety disorder
  • Has a primary care clinician listed in the patient's medical record
  • Has access to or agrees to be enrolled in the electronic health record patient portal and consents to be contacted via these modalities
  • Able to read/speak English or Spanish language
  • Is age ≥18 years old

Who cannot join

  • Any individual not meeting all inclusion criteria

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Mark A Clapp, MD, MPH contact

617-726-2000

mark.clapp@mgh.harvard.edu

United States1 site, 1 recruiting
  • Massachusetts General Hospital

    Boston, Massachusetts, 02115

    Recruiting

Other trials in United States

About this study

Official title: Bridges to Primary Care: Transforming Postpartum Primary Care Coordination for People With Chronic Conditions

The lack of postpartum primary care coordination is a missed opportunity to increase primary care engagement and manage chronic conditions early in life, especially for the >30% of pregnant people who have or are at risk for these conditions. This study aims to increase postpartum primary care engagement, quality, and experience by strengthening postpartum transitions to primary care using a behavioral economics-informed, multi-component intervention integrated into usual inpatient postpartum care. Using a randomized controlled trial and repeated outcome assessments through administrative and survey data, this study will generate rigorous, actionable evidence to ensure primary care coordination becomes standard postpartum care practice, potentially catalyzing sustained primary care engagement throughout life.

Read the detailed description

Over 30% of pregnant people have at least one chronic medical condition, and 20% have certain prenatal conditions (e.g., pregnancy-related hypertension, gestational diabetes) that increase the risk of chronic disease later in life. While patients with these conditions are typically highly engaged in prenatal care, they encounter a "postpartum cliff" in health system support after delivery; many receive no postpartum primary care at all despite having ongoing medical needs. At a time of increased stress, sleep deprivation, and competing demands, they must navigate administrative burdens in accessing primary care, often without scheduling assistance or any formal handoff between their obstetric and primary care clinician (PCP). These burdens may lead to avoided or delayed postpartum primary care, exacerbating health inequities that existed prenatally even for those fortunate enough to have a PCP. Given the many benefits of primary care, this lack of obstetric-to-primary care coordination represents a missed opportunity to increase primary care engagement and manage chronic conditions earlier in life. The primary objective is to increase postpartum primary care engagement, quality, and experience by strengthening obstetric-to-primary care coordination using a behavioral economics-informed intervention. The intervention, integrated into routine inpatient postpartum care, includes default PCP visit scheduling, tailored nudge messages to patients, ongoing care recommendations sent to the PCP, and a summary of recommendations after pregnancy given to the patient. Using a robust randomized controlled trial of 1,320 participants that is built off of the team's pilot study, the proposed study will: (Aim 1) measure the intervention's impact on postpartum primary care visit completion, sustained engagement, and disparities in these outcomes; (Aim 2) measure the intervention's impact on high-value primary care service use; and (Aim 3) measure the intervention's impact on patient experience. The study will generate rigorous, actionable evidence to ensure primary care coordination becomes standard postpartum care practice and will provide insight into postpartum patients' health care experiences. By targeting a vulnerable population at a time of great need and opportunity, postpartum-to-primary care coordination has the potential to catalyze sustained primary care engagement throughout life and improve long-term health.

Being tested
Facilitated Transition to Primary Care
Keywords
Postpartum Care, Primary Care, Care Transitions, Chronic Disease
Medical subject headings
Hypertension, Diabetes Mellitus, Anxiety Disorders, Depression, Obesity, Chronic Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Facilitated Transition to Primary CareOther

    The intervention includes default PCP visit scheduling, tailored nudge messages to patients, ongoing care recommendations sent to the PCP, and a summary of recommendations after pregnancy given to the patient.

Study groups in NCT06557005
Study groupRoleWhat they receive
Routine CareNo interventionRoutine postpartum care
Facilitated Transition GroupActive comparatorThe intervention is integrated into routine inpatient postpartum care and includes the following components: default PCP visit scheduling, tailored nudge messages to patients, ongoing care recommendations sent to the PCP, and a summary of recommendations after pregnancy given to the patient.
Receives: Other: Facilitated Transition to Primary Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Completion of a primary care visit

    Observation of a visit with a primary care practitioner (defined as physicians and advanced practice clinicians affiliated with the following medical specialties: internal medicine, family medicine, pediatrics and adolescent medicine, and gynecology).

    Measured: 155 days after date of delivery

  2. Receipt of condition-specific recommended health screening and counseling by a primary care practitioner

    For individuals with gestational hypertensive disorders, appropriate management is defined as blood pressure screening by a primary care practitioner as documented in the electronic health record.

    For individuals with gestational diabetes, appropriate management is defined as observation of a postpartum glucose screening testing (e.g., GTT, HgbA1c) in the electronic health record.

    For individuals with chronic conditions, appropriate management is defined as receipt of both condition-specific screening (mood, weight, blood pressure and/or diabetes screening) and receipt of counseling, discussion of a management, and/or referral for or acknowledgment of subspecialist management for that condition by a primary care practitioner as documented in the electronic health record. "

    Measured: 155 days after date of delivery

  3. Self-report of having a known, reliable primary care practitioner

    The outcome is the Self-report of having a known, reliable primary care practitioner (doctor, nurse practitioner, or physician's assistant).

    Measured: 155 days after date of delivery

  4. Self-report of mental health

    Edinburgh Perinatal Depression Scale will be administered and the total EPDS score compared.

    Measured: 155 days after date of delivery

Secondary outcomes (41)
  1. Completion of an annual exam with a primary care practitioner

    Observation of an annual exam or health care maintenance visit with a primary care practitioner (defined as physicians and advanced practice clinicians affiliated with the following medical specialties: internal medicine, family medicine, pediatrics and adolescent medicine, and gynecology).

    Measured: 155 days after date of delivery

  2. Self-report of completion of a primary care visit

    Self-report of a visit with a primary care practitioner (defined as physicians and advanced practice clinicians affiliated with the following medical specialties: internal medicine, family medicine, pediatrics and adolescent medicine, and gynecology) for any reason.

    Measured: 155 days after date of delivery

  3. Self-report of an annual exam with a primary care practitioner

    Self-report of an annual exam or health care maintenance visit with a primary care practitioner (defined as physicians and advanced practice clinicians affiliated with the following medical specialties: internal medicine, family medicine, pediatrics and adolescent medicine, and gynecology).

    Measured: 155 days after date of delivery

  4. Completion of a primary care visit

    Observation of a visit with a primary care practitioner for any reason.

    Measured: 365 days after date of delivery

  5. Self-report of completion of a primary care visit

    Self-report of a visit with a primary care practitioner (defined as physicians and advanced practice clinicians affiliated with the following medical specialties: internal medicine, family medicine, pediatrics and adolescent medicine, and gynecology) for any reason.

    Measured: 365 days after date of delivery

  6. Completion of an annual exam with a primary care practitioner

    Observation of an annual exam or health care maintenance visit with a primary care practitioner (defined as physicians and advanced practice clinicians affiliated with the following medical specialties: internal medicine, family medicine, pediatrics and adolescent medicine, and gynecology).

    Measured: 365 days after date of delivery

  7. Self-report of an annual exam with a primary care practitioner

    Self-report of an annual exam or health care maintenance visit with a primary care practitioner (defined as physicians and advanced practice clinicians affiliated with the following medical specialties: internal medicine, family medicine, pediatrics and adolescent medicine, and gynecology).

    Measured: 365 days after date of delivery

  8. Repeated primary care practitioner engagement

    Observation of two or more primary care practitioner visits for any reason.

    Measured: 365 days after date of delivery

  9. Self-report of repeated primary care practitioner engagement

    Self-report of two or more primary care practitioner visits for any reason.

    Measured: 365 days after date of delivery

  10. Extent of primary care practitioner engagement

    Number of primary care practitioner visits for any reason.

    Measured: 365 days after date of delivery

  11. Self-report of extent of primary care practitioner engagement

    Self-report of the number of primary care practitioner visits for any reason.

    Measured: 365 days after date of delivery

  12. Completion of a primary care visit

    Observation of a visit with a primary care practitioner for any reason.

    Measured: 548 days after date of delivery

  13. Completion of an annual exam with a primary care practitioner

    Observation of an annual exam or health care maintenance visit with a primary care practitioner.

    Measured: 548 days after date of delivery

  14. Repeated primary care practitioner engagement

    Observation of two or more primary care practitioner visits for any reason.

    Measured: 548 days after date of delivery

  15. Extent of primary care practitioner engagement

    Number of primary care practitioner visits for any reason.

    Measured: 548 days after date of delivery

  16. Self-report of receipt of condition-specific recommended health screening and counseling by a primary care practitioner

    For individuals with gestational hypertensive disorders, appropriate management is defined as blood pressure screening by a primary care practitioner as reported by the participant.

    For individuals with gestational diabetes, appropriate management is defined as observation of a postpartum glucose screening testing (e.g., GTT, HgbA1c) as reported by the participant.

    For individuals with chronic conditions, appropriate management is defined as receipt of both condition-specific screening (mood, weight, blood pressure and/or diabetes screening) and receipt of counseling, discussion of a management, and/or referral for or acknowledgment of subspecialist management for that condition by a primary care practitioner as reported by the participant.

    Measured: 155 days after date of delivery

  17. Receipt of recommended screening and counseling for chronic condition by primary care practitioner

    For individuals with chronic conditions, appropriate management is defined as receipt of both condition-specific screening (mood, weight, blood pressure and/or diabetes screening) and receipt of counseling, discussion of a management, and/or referral for or acknowledgment of subspecialist management for that condition by a primary care practitioner as documented in the electronic health record.

    Measured: 155 days after date of delivery

  18. Receipt of recommended screening for gestational condition by primary care practitioner

    For individuals with gestational hypertensive disorders, appropriate management is defined as blood pressure screening by a primary care practitioner as documented in the electronic health record.

    For individuals with gestational diabetes, appropriate management is defined as observation of a postpartum glucose screening testing (e.g., GTT, HgbA1c) in the electronic health record."

    Measured: 155 days after date of delivery

  19. Receipt of recommended screening and counseling for chronic condition by primary care practitioner

    For individuals with chronic conditions, appropriate management is defined as receipt of both condition-specific screening (mood, weight, blood pressure and/or diabetes screening) and receipt of counseling, discussion of a management, and/or referral for or acknowledgment of subspecialist management for that condition by a primary care practitioner as documented in the electronic health record.

    Measured: 365 days after date of delivery

  20. Receipt of recommended screening for gestational condition by primary care practitioner

    For individuals with gestational hypertensive disorders, appropriate management is defined as blood pressure screening by a primary care practitioner as documented in the electronic health record.

    For individuals with gestational diabetes, appropriate management is defined as observation of a postpartum glucose screening testing (e.g., GTT, HgbA1c) in the electronic health record.

    Measured: 365 days after date of delivery

  21. Receipt of recommended screening and counseling for chronic condition by primary care practitioner

    For individuals with chronic conditions, appropriate management is defined as receipt of both condition-specific screening (mood, weight, blood pressure and/or diabetes screening) and receipt of counseling, discussion of a management, and/or referral for or acknowledgment of subspecialist management for that condition by a primary care practitioner as documented in the electronic health record.

    Measured: 548 days after date of delivery

  22. Receipt of recommended screening for gestational condition by primary care practitioner

    For individuals with gestational hypertensive disorders, appropriate management is defined as blood pressure screening by a primary care practitioner as documented in the electronic health record.

    For individuals with gestational diabetes, appropriate management is defined as observation of a postpartum glucose screening testing (e.g., GTT, HgbA1c) in the electronic health record.

    Measured: 548 days after date of delivery

  23. Self-report of receipt of recommended screening and counseling for chronic condition by primary care practitioner

    For individuals with chronic conditions, appropriate management is defined as receipt of both condition-specific screening (mood, weight, blood pressure and/or diabetes screening) and receipt of counseling, discussion of a management, and/or referral for or acknowledgment of subspecialist management for that condition by a primary care practitioner as reported by the participant.

    Measured: 365 days after date of delivery

  24. Self-report of receipt of recommended screening for gestational condition by primary care practitioner

    For individuals with gestational hypertensive disorders, appropriate management is defined as blood pressure screening by a primary care practitioner as reported by the participant.

    For individuals with gestational diabetes, appropriate management is defined as observation of a postpartum glucose screening testing (e.g., GTT, HgbA1c) as reported by the participant. "

    Measured: 365 days after date of delivery

  25. Self-report of having a known, reliable primary care practitioner

    Participant report of having a known, reliable primary care practitioner (doctor, nurse practitioner, or physician's assistant).

    Measured: 365 days after date of delivery

  26. Urgent or emergent care use

    Emergency department or urgent care visit for any reason as documented in the electronic health record.

    Measured: 155 days after date of delivery

  27. Self-report of urgent or emergent care use

    Emergency department or urgent care visit for any reason as documented as reported by the participant.

    Measured: 155 days after date of delivery

  28. Urgent or emergent care use

    Emergency department or urgent care visit for any reason as documented in the electronic health record.

    Measured: 365 days after date of delivery

  29. Self-report of urgent or emergent care use

    Emergency department or urgent care visit for any reason as reported by the participant.

    Measured: 365 days after date of delivery

  30. Self-report of mental health

    Edinburgh Perinatal Depression Scale score as reported by the participant.

    Measured: 365 days after date of delivery

  31. Urgent or emergent care use

    Emergency department or urgent care visit for any reason as documented in the electronic health record.

    Measured: 584 days after date of delivery

  32. Interpregnancy interval

    Defined as the time (in days) from date of delivery until subsequent date of conception.

    Measured: 365 days after date of delivery

  33. Interpregnancy interval

    Defined as the time (in days) from date of delivery until subsequent date of conception.

    Measured: 584 days after date of delivery

  34. Prescription or documentation of medication use for the treatment of a pre-existing or newly diagnosed mood or anxiety disorder

    Observation of a prescription for or provider documentation noting the use of a medication for the treatment of a pre-existing or newly diagnosed mood or anxiety disorder in the electronic health record.

    Measured: 155 days

  35. Prescription or documentation of medication use for the treatment of a pre-existing or newly diagnosed mood or anxiety disorder

    Observation of a prescription for or provider documentation noting the use of a medication for the treatment of a pre-existing or newly diagnosed mood or anxiety disorder in the electronic health record.

    Measured: 365 days

  36. Prescription or documentation of medication use for the treatment of a pre-existing or newly diagnosed mood or anxiety disorder

    Observation of a prescription for or provider documentation noting the use of a medication for the treatment of a pre-existing or newly diagnosed mood or anxiety disorder in the electronic health record.

    Measured: 584 days

  37. Contraception use

    The use of any form of contraception as documented in the electronic health record

    Measured: 155 days

  38. Contraception use

    The use of any form of contraception as documented in the electronic health record

    Measured: 365 days

  39. Contraception use

    The use of any form of contraception as documented in the electronic health record

    Measured: 584 days

  40. Self-report of contraception

    Self-report of using contraception or discussing family planning/contraception

    Measured: 155 days

  41. Self-report of contraception

    Self-report of using contraception or discussing family planning/contraception

    Measured: 365 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Aug 2024
  2. Study start23 May 2025
  3. Primary completion23 May 2027 (estimated)
  4. Study completion23 May 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Care provider, Investigator, Outcomes assessor
Enrolment
1,320 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06557005
Sponsor's protocol ID
2024P002210
Other IDs
R01HS030245-01
Status last verified
Jul 2026
First submitted
13 Aug 2024
Last updated
13 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Data sets generated for this analysis will be preserved and shared publicly after planned primary and secondary analyses are completed by the research team or at the end of the award, whichever occurs last. Data will be preserved for at least 5 years after public posting to ensure outside investigators can access and use this information for related research. Study metadata, code, and a deidentified data set that includes all collected trial data will be publicly available, without restricted access, on the Harvard Dataverse Repository.

Questions about this trial

What is this clinical trial studying?

A study testing Facilitated Transition to Primary Care in people with Hypertension and Diabetes, run by Massachusetts General Hospital at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 14 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 13 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Mark A Clapp, MD, MPH (617-726-2000, mark.clapp@mgh.harvard.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Completion of a primary care visit (time frame: 155 days after date of delivery). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in